Rebecca Green
About Rebecca Green
Rebecca Green is a Senior Principal Scientist at Bristol Myers Squibb with a PhD in Chemistry from the University of California, Berkeley. She has published multiple research papers on oncology and immunotherapy and holds a patent for a novel cancer treatment compound.
Title
Rebecca Green currently holds the title of Senior Principal Scientist at Bristol Myers Squibb. Her role involves high-level scientific research and leadership responsibilities in the field of oncology and immunotherapy.
Company
Rebecca Green is employed by Bristol Myers Squibb, a global biopharmaceutical company. She has been with the company for several years, progressing through various significant roles including Research Investigator II, Senior Research Investigator I, Principal Scientist, and now Senior Principal Scientist.
Education and Expertise
Rebecca Green earned her Doctor of Philosophy (PhD) in Chemistry from the University of California, Berkeley, where she studied from 2011 to 2016. Prior to that, she achieved her Bachelor of Science (BS) degree in Chemistry from McGill University, where she studied from 2008 to 2011. Her education laid a solid foundation for her expertise in oncology and immunotherapy.
Achievements
Rebecca Green received the 'Excellence in Research' award at Bristol Myers Squibb in 2020, highlighting her valuable contributions. She holds a patent for a novel compound used in cancer treatment, demonstrating her innovative research capabilities. Furthermore, she has presented her research findings at notable conferences, including the American Association for Cancer Research (AACR) annual meeting in 2021.
Mentorship and Publications
Rebecca Green is actively involved in mentoring junior scientists and interns at Bristol Myers Squibb, sharing her expertise and guiding new talent in the field. She has also published multiple research papers in peer-reviewed journals, focusing on oncology and immunotherapy, contributing significantly to the scientific community.